Results 131 to 140 of about 15,914 (183)

A signature constructed with circadian rhythm-related genes to predict the prognosis and therapy response for low-grade gliomas. [PDF]

Discov Oncol
Zhou Y, Ke R, Hu Z, Wang Z.
europepmc   +1 more source

SKP2 protein as a prognostic biomarker for glioma and promotes tumor progression by regulating the cell cycle. [PDF]

Sci Rep
Guan L, Li H, Liu Y, Ouyang J, Yan C, Liu F.   +5 more
europepmc   +1 more source

Recombination between fragile regions associated with chromosomal rearrangements in glioblastoma can be mediated by RAGs. [PDF]

iScience
Paranjape A, Kumari S, Sahu LR, Mondal A, Kunhiraman S, Sharma M A, Nilavar NM, Choudhary B, Raghavan SC.   +8 more
europepmc   +1 more source

Erratum: MicroRNA-625 inhibits the proliferation and increases the chemosensitivity of glioma by directly targeting AKT2. [PDF]

Am J Cancer Res
Zhang J, Zhang J, Zhang J, Qiu W, Xu S, Yu Q, Liu C, Wang Y, Lu A, Zhang J, Lu X.   +10 more
europepmc   +1 more source

Selective targeting of glioma via the SCARB2 receptor: transcriptomic, proteomic and <i>in vitro</i> functional validation for Enterovirus A71 virotherapy. [PDF]

Front Cell Infect Microbiol
Li J, Zhang Y, Zhang J, Hao Z, Yin X.
europepmc   +1 more source

CAMK2B Impacts the Proliferation, Invasion, and Migration of Glioma Cells via the Ras/Raf/MEK/ERK Signaling Pathway. [PDF]

Oncol Res
Zhang S, Li J, Jin Q, Zhu S, Yan H, Wang Y, Song Z, Liu L.   +7 more
europepmc   +1 more source

In vitro generated macrophages reflect the immunosuppressive phenotype of in vivo glioblastoma-associated macrophages. [PDF]

Oncoimmunology
Nazzaro M, Mardis ER, Artomov M, Juenger E, Lyberger J, Damante M, Behbehani G, Sarkar S, Rajappa P.   +8 more
europepmc   +1 more source

Engrailed 1 promotes immune evasion and chemoresistance in glioma through single cell and CeRNA network analyses. [PDF]

Sci Rep
Jia Z, Wang Y, Yao J, Zhang L, Liang X, Wen T, Li W, Li Z.   +7 more
europepmc   +1 more source

Oncolytic virus OVV-03 enhances CAR-T cell therapy against glioblastoma via immune modulation and specific HER2 upregulation. [PDF]

Oncoimmunology
Tang Y, E Q, Ma L, Li X, Zhang Y, Wang W, Jiang Z, Zhang X, Hou Y, Du J, Zhu Y, Dong H, Xu Y, Tian T, Cheng L, Ma Q, Li J, Zhou G, Huang Y.   +18 more
europepmc   +1 more source

Anticancer potential of natural bioactive compounds saponins in glioblastoma multiforme. [PDF]

Front Pharmacol
Elsori D, Alshabrmi FM, Alharbi AM, Saeed M, Singh A, Pandey P, Rab SO, Khan F.   +7 more
europepmc   +1 more source